GlassScriptPhysician profile
Cristian Andrade
NPI 1265443980
$327.59
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $51.71 · 2021: $107 · 2022: $22.44.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $80.25 | 2019 | |
| Janssen Pharmaceuticals, INC | $62.47 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.55 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $38.46 | 2019 | |
| Celgene Corporation | $30.30 | 2021 | |
| Merck Sharp & Dohme LLC | $22.46 | 2021 | |
| Abbvie INC. | $16.18 | 2020 | |
| Pfizer INC. | $13.98 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.94 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cristian Andrade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.